Despite being the gold-standard for clinical practice, systematic reviews remain atypical in preclinical research.17 Here, we aim to address this gap by performing a systematic review and meta-analysis of SMN-targeting therapies in mouse models of SMA. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.